6 results on '"Lee, Shu‐Ru"'
Search Results
2. Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study.
- Author
-
Hsu, Cheng‐Lung, Wen, Yu‐Wen, Wang, Hung‐Ming, Hsieh, Chia‐Hsun, Liao, Chi‐Ting, Lee, Li‐Yu, Ng, Shu‐Hang, Lin, Chien‐Yu, Chen, Wen‐Cheng, Lin, Jin‐Ching, Tsai, Yao‐Te, Lee, Shu‐Ru, Chien, Chih‐Yen, Hua, Chun‐Hung, Wang, Cheng Ping, Chen, Tsung‐Ming, Terng, Shyuang‐Der, Tsai, Chi‐Ying, Fan, Kang‐Hsing, and Yeh, Chih‐Hua
- Subjects
INDUCTION chemotherapy ,SQUAMOUS cell carcinoma ,NEOADJUVANT chemotherapy ,OVERALL survival ,SURVIVAL rate - Abstract
Background: While surgery remains the primary treatment for oral squamous cell carcinoma (OCSCC), induction chemotherapy (IC) can be used as a bridging or neoadjuvant therapy. This nationwide study in Taiwan examines the survival outcomes of OCSCC patients who received IC before surgery. Methods: We analyzed data from 29,891 patients with OCSCC. Of these, 29,058 initially underwent surgery (OP group), whereas 833 received IC before surgery (IC + OP group). A propensity score (PS)‐matched analysis (4, 1 ratio, 3260 vs. 815 patients) was performed considering tumor subsite, sex, age, Charlson comorbidity index, clinical T1–T4b tumors, clinical N0–3 disease, and clinical stage I–IV. Results: In the PS‐matched cohort, the 5‐year disease‐specific survival (DSS) and overall survival (OS) rates were 65% and 57%, respectively. When comparing the OP and IC + OP groups, the 5‐year DSS rates were 66% and 62%, respectively (p = 0.1162). Additionally, the 5‐year OS rates were 57% and 56%, respectively (p = 0.9917). No significant intergroup differences in survival were observed for specific subgroups with cT4a tumors, cT4b tumors, cN3 disease, pT4b tumors, and pN3 disease. However, for patients with pT4a tumors, the OP group demonstrated superior 5‐year outcomes compared to the IC + OP group, with a DSS of 62% versus 52% (p = 0.0006) and an OS of 53% versus 44% (p = 0.0060). Notably, patients with cT2–3, cN1, and c‐Stage II disease in the IC + OP group were significantly more likely to achieve pT0–1 status (p < 0.05). Conclusions: Following PS matching, the IC + OP group generally exhibited similar prognosis to the OP group. However, for pT4a tumors, the OP group showed superior 5‐year outcomes. While IC may not universally improve survival, it could be advantageous for patients who respond positively to the treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Prognostic impact of elective tracheotomy in resected oral cavity squamous cell carcinoma: A nationwide cohort study.
- Author
-
Fang, Ku‐Hao, Kang, Chung‐Jan, Lee, Li‐Yu, Ng, Shu‐Hang, Lin, Chien‐Yu, Chen, Wen‐Cheng, Lin, Jin‐Ching, Tsai, Yao‐Te, Lee, Shu‐Ru, Chien, Chih‐Yen, Hua, Chun‐Hung, Wang, Cheng Ping, Chen, Tsung‐Ming, Terng, Shyuang‐Der, Tsai, Chi‐Ying, Wang, Hung‐Ming, Hsieh, Chia‐Hsun, Fan, Kang‐Hsing, Yeh, Chih‐Hua, and Lin, Chih‐Hung
- Subjects
TRACHEOTOMY ,SQUAMOUS cell carcinoma ,LENGTH of stay in hospitals ,COHORT analysis ,OVERALL survival ,SURVIVAL rate - Abstract
Background: Elective tracheotomy is commonly performed in resected oral squamous cell carcinoma (OCSCC) to maintain airway patency. However, the indications for this procedure vary among surgeons. This nationwide study evaluated the impact of tracheotomy on both the duration of in‐hospital stay and long‐term survival outcomes in patients with OCSCC. Methods: A total of 18,416 patients with OCSCC were included in the analysis, comprising 7981 patients who underwent elective tracheotomy and 10,435 who did not. The primary outcomes assessed were 5‐year disease‐specific survival (DSS) and overall survival (OS). To minimize potential confounding factors, a propensity score (PS)‐matched analysis was performed on 4301 patients from each group. The duration of hospital stay was not included as a variable in the PS‐matched analysis. Results: Prior to PS matching, patients with tracheotomy had significantly lower 5‐year DSS and OS rates compared to those without (71% vs. 82%, p < 0.0001; 62% vs. 75%, p < 0.0001, respectively). Multivariable analysis identified tracheotomy as an independent adverse prognostic factor for 5‐year DSS (hazard ratio = 1.10 [1.03–1.18], p = 0.0063) and OS (hazard ratio = 1.10 [1.04–1.17], p = 0.0015). In the PS‐matched cohort, the 5‐year DSS was 75% for patients with tracheotomy and 76% for those without (p = 0.1488). Five‐year OS rates were 66% and 67%, respectively (p = 0.0808). Prior to PS matching, patients with tracheotomy had a significantly longer mean hospital stay compared to those without (23.37 ± 10.56 days vs. 14.19 ± 8.34 days; p < 0.0001). Following PS matching, the difference in hospital stay duration between the two groups remained significant (22.34 ± 10.25 days vs. 17.59 ± 9.54 days; p < 0.0001). Conclusions: While elective tracheotomy in resected OCSCC patients may not significantly affect survival, it could be associated with prolonged hospital stays. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system?
- Author
-
Chen, Tsung‐Ming, primary, Terng, Shyuang‐Der, additional, Lee, Li‐Yu, additional, Lee, Shu‐Ru, additional, Ng, Shu‐Hang, additional, Kang, Chung‐Jan, additional, Lin, Jin‐Ching, additional, Chien, Chih‐Yen, additional, Hua, Chun‐Hung, additional, Wang, Cheng Ping, additional, Chen, Wen‐Cheng, additional, Tsai, Yao‐Te, additional, Tsai, Chi‐Ying, additional, Lin, Chien‐Yu, additional, Fan, Kang‐Hsing, additional, Wang, Hung‐Ming, additional, Hsieh, Chia‐Hsun, additional, Yeh, Chih‐Hua, additional, Lin, Chih‐Hung, additional, Tsao, Chung‐Kan, additional, Cheng, Nai‐Ming, additional, Fang, Tuan‐Jen, additional, Huang, Shiang‐Fu, additional, Lee, Li‐Ang, additional, Fang, Ku‐Hao, additional, Wang, Yu‐Chien, additional, Lin, Wan‐Ni, additional, Hsin, Li‐Jen, additional, Yen, Tzu‐Chen, additional, Wen, Yu‐Wen, additional, and Liao, Chun‐Ta, additional
- Published
- 2024
- Full Text
- View/download PDF
5. cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinoma
- Author
-
Lin, Chien‐Yu, primary, Lee, Li‐Yu, additional, Cheng, Nai‐Ming, additional, Lee, Shu Ru, additional, Tsai, Chi‐Ying, additional, Hsueh, Chuen, additional, Fan, Kang‐Hsing, additional, Wang, Hung‐Ming, additional, Hsieh, Chia‐Hsun, additional, Ng, Shu‐Hang, additional, Yeh, Chih‐Hua, additional, Lin, Chih‐Hung, additional, Tsao, Chung‐Kan, additional, Fang, Tuan‐Jen, additional, Huang, Shiang‐Fu, additional, Lee, Li‐Ang, additional, Kang, Chung‐Jan, additional, Fang, Ku‐Hao, additional, Wang, Yu‐Chien, additional, Lin, Wan‐Ni, additional, Hsin, Li‐Jen, additional, Yen, Tzu‐Chen, additional, and Liao, Chun‐Ta, additional
- Published
- 2021
- Full Text
- View/download PDF
6. Comparing the clinical outcomes of initial surgery and primary definitive radiotherapy with a dosage of 6600 cGy or higher in cT1-2N0M0 oral cavity squamous cell carcinoma: A nationwide cohort study.
- Author
-
Lin CY, Chen WC, Wen YW, Fan KH, Lin JC, Ng SH, Tsai YT, Lee SR, Kang CJ, Lee LY, Chien CY, Hua CH, Wang CP, Chen TM, Terng SD, Tsai CY, Wang HM, Hsieh CH, Yeh CH, Lin CH, Tsao CK, Cheng NM, Fang TJ, Huang SF, Lee LA, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, and Liao CT
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Taiwan epidemiology, Neoplasm Staging, Radiotherapy Dosage, Treatment Outcome, Propensity Score, Carcinoma, Squamous Cell radiotherapy, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell surgery, Carcinoma, Squamous Cell pathology, Adult, Retrospective Studies, Survival Rate, Squamous Cell Carcinoma of Head and Neck radiotherapy, Squamous Cell Carcinoma of Head and Neck mortality, Squamous Cell Carcinoma of Head and Neck surgery, Squamous Cell Carcinoma of Head and Neck pathology, Mouth Neoplasms radiotherapy, Mouth Neoplasms surgery, Mouth Neoplasms mortality, Mouth Neoplasms pathology
- Abstract
Background: To compare the clinical outcomes of two treatment modalities, initial surgery and primary definitive radiotherapy (RT), in Taiwanese patients diagnosed with cT1-2N0M0 oral cavity squamous cell carcinoma (OCSCC)., Methods: Between 2011 and 2019, we analyzed data for 13,542 cT1-2N0M0 patients who underwent initial surgery (n = 13,542) or definitive RT with a dosage of at least 6600 cGy (n = 145) for the treatment of OCSCC. To account for baseline differences, we employed propensity score (PS) matching, resulting in two well-balanced study groups (initial surgery, n = 580; definitive RT, n = 145)., Results: Before PS matching, the 5-year disease-specific survival (DSS) rates were 88% for the surgery group and 58% for the RT group. After PS matching, the 5-year DSS rates of the two groups were 86% and 58%, respectively. Similarly, the 5-year overall survival (OS) rates before PS matching were 80% for the surgery group and 36% for the RT group, whereas after PS matching, they were 73% and 36%, respectively. All these differences were statistically significant (p < 0.0001). A multivariable analysis identified treatment with RT, older age, stage II tumors, and a higher burden of comorbidities as independent risk factors for both DSS and OS. We also examined the 5-year outcomes for various subgroups (margin ≥5 mm, margin <5 mm, positive margins, RT combined with chemotherapy, and RT alone) as follows: DSS, 89%/88%/79%/63%/51%, respectively, p < 0.0001; OS, 82%/79%/68%/39%/32%, respectively, p < 0.0001., Conclusions: In Taiwanese patients with cT1-2N0M0 OCSCC, a remarkably low proportion (1.1%) completed definitive RT. A significant survival disparity of 30% was observed between patients who underwent initial surgery and those who received definitive RT. Interestingly, even patients from the surgical group with positive surgical margins exhibited a significantly superior survival compared to those in the definitive RT group., (© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.